You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
With a Foreword by Sydney Brenner (Nobel laureate in Physiology or Medicine, 2002)This biography details the life of Paul Berg (Emeritus Professor at Stanford University), tracing Berg's life from birth, in 1926, to the present, with special emphasis on his enormous scientific contributions, including being the first to develop technology that led to gene cloning science. In 1980, Berg received a Nobel Prize in chemistry for this work.In addition to his contributions in the research laboratory, Berg orchestrated and oversaw a historic meeting at Asilomar, California that centered on a threatening controversy surrounding the perception by some of the harmful potential of recombinant DNA techn...
With a Foreword by Sydney Brenner (Nobel laureate in Physiology or Medicine, 2002) This biography details the life of Paul Berg (Emeritus Professor at Stanford University), tracing Berg's life from birth, in 1926, to the present, with special emphasis on his enormous scientific contributions, including being the first to develop technology that led to gene cloning science. In 1980, Berg received a Nobel Prize in chemistry for this work. In addition to his contributions in the research laboratory, Berg orchestrated and oversaw a historic meeting at Asilomar, California that centered on a threatening controversy surrounding the perception by some of the harmful potential of recombinant DNA tec...
George Beadle was a towering scientific figure whose work from the 1930s to 1960 marked the transition from classical genetics to the molecular era. Among other distinctions, he made the pivotal, Nobel Prize–winning discovery with Edward Tatum that the role of genes is to specify proteins. From 1946 to 1960 he led the Caltech Biology Division, rebuilding it to a powerhouse in molecular biology, and afterwards became a successful President of the University of Chicago. This is the first biography of a giant of genetics, written by two of the field's most distinguished contributors, Paul Berg and Maxine Singer.
The seemingly unlimited reach of powerful biotechnologies and the attendant growth of the multibillion-dollar industry have raised difficult questions about the scientific discoveries, political assumptions, and cultural patterns that gave rise to for-profit biological research. Given such extraordinary stakes, a history of the commercial biotechnology industry must inquire far beyond the predictable attention to scientists, discovery, and corporate sales. It must pursue how something so complex as the biotechnology industry was born, poised to become both a vanguard for contemporary world capitalism and a focal point for polemic ethical debate. In Biotech, Eric J. Vettel chronicles the stor...
A more unlikely world opera star than Paul Frey could not be found. Born into a conservative order Mennonite farming family in rural Ontario, Canada in 1941, he was a high school dropout. His first career was as a truck driver, transporting livestock to market. But he was a young man with a powerful and true tenor voice, and a desire to sing opera. Entering opera school unable to read musical notes or count beats, Frey was offered primarily chorus roles during training and after graduation. Frustrated, he moved to Switzerland in 1977, signing a contract with the Theater Basel as house tenor. In 1987, Frey came to the attention of Wolfgang Wagner of the famed Bayreuth Opera House in Bayreuth, Germany. He was chosen to star in Bayreuth's Werner-Herzog-directed production of Richard Wagner's Lohengrin. At Bayreuth, Frey became a star and the world sat up and took notice. Offered lead roles from opera houses across the globe, Paul Frey was compared to the greatest of tenors, including Canadian Jon Vickers. Retiring in 2005, Paul Frey lives today in "Mennonite Country," where he was born and raised.
This biographical collection highlights individuals who made outstanding achievements in the arenas of pharmaceuticals and biotechnology. Pharmaceutical Achievers presents chronologically the major directions of pharmaceutical research and, in their historical context, the breakthroughs in treating various diseases. It concludes with a look at tomorrow's medicines. This work is particularly useful in the classroom, where its accounts of challenges and triumphs may inspire students to consider careers that support pharmaceutical research and development.
The promise of genetic engineering in the early 1970s to profoundly reshape the living world activated a variety of social interests in its future promotion and control. With public safety, gene patents, and the future of genetic research at stake, a wide range of interest groups competed for control over this powerful new technology. In this comparative study of the development of regulatory policy for genetic engineering in the United States and the United Kingdom, Susan Wright analyzes government responses to the struggles among corporations, scientists, universities, trade unions, and public interest groups over regulating this new field. Drawing on archival materials, government records...
The Fourier transform and the Laplace transform of a positive measure share, together with its moment sequence, a positive definiteness property which under certain regularity assumptions is characteristic for such expressions. This is formulated in exact terms in the famous theorems of Bochner, Bernstein-Widder and Hamburger. All three theorems can be viewed as special cases of a general theorem about functions qJ on abelian semigroups with involution (S, +, *) which are positive definite in the sense that the matrix (qJ(sJ + Sk» is positive definite for all finite choices of elements St, . . . , Sn from S. The three basic results mentioned above correspond to (~, +, x* = -x), ([0, 00[, +,...
A biography of one of America's most famous and important molecular biologists.